¼¼°èÀÇ ¼Ò¾Æ ¹æ»ç¼±ÇÐ ½ÃÀå
Pediatric Radiology
»óǰÄÚµå : 1737326
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 375 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,015,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,045,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼Ò¾Æ ¹æ»ç¼±ÇÐ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 78¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 65¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼Ò¾Æ ¹æ»ç¼±ÇÐ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 3.1%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 78¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÃÊÀ½ÆÄ´Â CAGR 2.3%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 37¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. MRI ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 18¾ï ´Þ·¯, Áß±¹Àº CAGR 5.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼Ò¾Æ ¹æ»ç¼±ÇÐ ½ÃÀåÀº 2024³â¿¡ 18¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 15¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 5.7%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 1.3%¿Í 2.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¼Ò¾Æ ¹æ»ç¼±ÇÐ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¼Ò¾Æ ¹æ»ç¼±ÇÐÀÌ ÀÇ·á ¿µ»ó Áø´ÜÀÇ ÇÏÀ§ Àü¹®ºÐ¾ß·Î Â÷º°È­µÇ°í ºü¸£°Ô ¹ßÀüÇϰí ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

¼Ò¾Æ ¹æ»ç¼±ÇÐÀº ¿µ¾Æ, À¯¾Æ, ¼Ò¾Æ, û¼Ò³â ƯÀ¯ÀÇ ÇØºÎÇÐÀû, »ý¸®Àû, ¹ß´ÞÀû Ư¡¿¡ ¸ÂÃá ¿µ»ó Áø´ÜÀÇ Áß¿äÇϰí Àü¹®ÀûÀÎ ºÐ¾ß·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¼ºÀÎ ¹æ»ç¼± Áø´Ü°ú ´Þ¸® ¼Ò¾Æ ¿µ»ó Áø´ÜÀº ¿¬·É¿¡ µû¶ó Å©°Ô ´Þ¶óÁö´Â ¿ªµ¿ÀûÀÎ ¼ºÀå ÆÐÅϰú Áúº´ ¾ç»óÀ» °í·ÁÇÏ¿© ¸ÂÃãÇü Àåºñ ¼³Á¤, ¹æ»ç¼±·® Á¶Àý, ÁøÁ¤ ÇÁ·ÎÅäÄÝ, Àü¹®ÀûÀÎ ÆÇµ¶ ±â¼úÀÌ ¿ä±¸µË´Ï´Ù. ÀÌ ¼­ºê ½ºÆä¼È¸®Æ¼´Â ¼±Ãµ¼º ±âÇü, °¨¿°, ¿Ü»ó, Á¾¾çÀ» Æ÷ÇÔÇÑ ¼Ò¾Æ ÁúȯÀÇ Á¶±â Áø´Ü, Ä¡·á °èȹ, Áúº´ ¸ð´ÏÅ͸µ¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖ½À´Ï´Ù.

¼±Ãµ¼º ½ÉÀåÁúȯ, ³¶Æ÷¼º¼¶À¯Áõ, °£Áú, ¼Ò¾Æ¾Ï µî ¼Ò¾Æ ¸¸¼ºÁúȯÀÇ Áõ°¡·Î ÷´Ü ¿µ»ó Áø´Ü¿¡ ´ëÇÑ ÀÓ»óÀû ¿ä±¸°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å»ý¾Æ ÁßȯÀÚ½Ç(NICU), ¼Ò¾Æ ÀÀ±Þ½Ç, ¼Ò¾Æ Àü¹® º´¿ø¿¡¼­´Â Áø´Ü Áö¿¬À» ÁÙÀÌ°í ¿¹Èĸ¦ °³¼±Çϱâ À§ÇØ ¹æ»ç¼±°ú Àü¿ë À¯´Ö¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ ¼Ò¾Æ Áß½ÉÀÇ Á¢±Ù ¹æ½ÄÀ» äÅÃÇϰí ÀÖ´Â °¡¿îµ¥, ¼Ò¾Æ ¹æ»ç¼±ÇÐÀº °¡Àå ¾î¸° ȯÀڵ鿡°Ô Á¤È®ÇÏ°í ¾ÈÀüÇÏ¸ç ½Ã±âÀûÀýÇÑ Áø´Ü Áö¿øÀ» º¸ÀåÇϱâ À§ÇÑ ±âº» ÃàÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¼Ò¾Æ ¹æ»ç¼±ÇÐÀÇ ¿ä±¸¿¡ ºÎÀÀÇϱâ À§ÇØ ¿µ»ó Áø´Ü ¾ç½Ä°ú ¾ÈÀü ±âÁØÀº ¾î¶»°Ô ÁøÈ­Çϰí Àִ°¡?

ÀÌ ºÐ¾ß¿¡¼­´Â ¼Ò¾Æ¿ëÀ¸·Î Á¶Á¤µÈ ¿µ»ó ±â¼úÀÌ ºü¸£°Ô ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ¹Ýº¹ À籸¼ºÀ» ÅëÇÑ Àú¼±·® CT(ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ) ½ºÄ³³Ê, °íÇØ»óµµ ÃÊÀ½ÆÄ °Ë»ç, ¼Ò¾Æ Àü¿ë MRI(ÀÚ±â°ø¸í¿µ»ó) ÇÁ·ÎÅäÄÝÀº Áø´ÜÀÇ Á¤È®¼ºÀ» À¯ÁöÇϸ鼭 ÇÇÆøÀ» ÃÖ¼ÒÈ­Çϰí ÀÖ½À´Ï´Ù. ¼Ò¾Æ Åõ½Ã½Ç, Á¶¿µ ÃÊÀ½ÆÄ(CEUS), 3D ¿µ»ó Áø´Üµµ ħ½ÀÀû ½Ã¼ú¿¡ ÀÇÁ¸ÇÏÁö ¾Ê°í ¼ÒÈ­±â, ºñ´¢±â, Ç÷°ü°è µîÀ» Æò°¡Çϱâ À§ÇØ ³Î¸® º¸±ÞµÇ°í ÀÖ½À´Ï´Ù.

¹æ»ç¼± ¾ÈÀüÀº ¿©ÀüÈ÷ Áß½ÉÀûÀÎ °ü½É»çÀ̸ç, ALARA(As Low As Reasonably Achievable) ¿øÄ¢ÀÌ ÇÁ·ÎÅäÄÝ¿¡ ±¤¹üÀ§ÇÏ°Ô Ã¤Åõǰí ÀÖ½À´Ï´Ù. Â÷Æó¹ý, ÀûÀÀÇü ¼±·® º¯Á¶¹ý, ÀÚµ¿ ÇÇÆø °ü¸® ½Ã½ºÅÛÀÌ ¿µ»ó ó¸® Ç÷§Æû¿¡ ÅëÇյǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À̹ÌÁö ÈÄó¸®, ³ëÀÌÁî Á¦°Å, AI Áø´ÜÀ» À§ÇÑ ¼ÒÇÁÆ®¿þ¾î µµ±¸´Â ÀçÃÔ¿µÀÇ Çʿ伺À» ÁÙ¿©ÁÖ°í ÀÖ½À´Ï´Ù. ¾Æµ¿ »ýȰ Àü¹®°¡, ½Ãû°¢ »ê¸¸, ºñ¾à¸®ÇÐÀû ÁøÁ¤Á¦¸¦ °®Ãá ¾Æµ¿ ģȭÀûÀΠȯ°æÀº Çù·Â°ú ½ºÄµÀÇ ÁúÀ» Çâ»ó½ÃŰ°í ¼Ò¾Æ ¿µ»ó Áø´ÜÀ»º¸´Ù ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î ¸¸µì´Ï´Ù.

¼Ò¾Æ¿µ»óÀÇÇÐ ¼­ºñ½º ¼ö¿ä¸¦ ÁÖµµÇÏ´Â ½Ã¼³, Áúȯ ÇÁ·ÎÆÄÀÏ, Áö¿ªÀº?

3Â÷ ÀÇ·á ¼Ò¾Æ º´¿ø, Çмú ÀÇ·á ¼¾ÅÍ, ¼Ò¾Æ Àü¹® Ŭ¸®´ÐÀÌ ¼Ò¾Æ ¹æ»ç¼± ¼­ºñ½ºÀÇ ÁÖ¿ä »ç¿ëÀÚÀÔ´Ï´Ù. ³ôÀº ¿µ»ó ¼ö¿ä´Â ½Å»ý¾Æ ÀÇ·á, ¼Ò¾Æ Á¤Çü¿Ü°ú, ½ÉÀåÇÐ, Á¾¾çÇÐ, ÀÀ±ÞÀÇ·á¿¡ ÁýÁߵǾî ÀÖ½À´Ï´Ù. ÀϹÝÀûÀÎ ÀûÀÀÁõÀ¸·Î´Â ½Å°æ ¹ß´Þ Æò°¡, °ñ°Ý Çü¼º ÀÌ»ó Æò°¡, ¿Ü»ó ¿µ»ó Áø´Ü, ¾Ï º´±â ºÐ·ù µîÀÌ ÀÖ½À´Ï´Ù. ¼±Ãµ¼º ±âÇü¾Æ ±³Á¤ ¹× Àå±â À̽ÄÀ» Æ÷ÇÔÇÑ ¼Ò¾Æ ¼ö¼úÀÇ Áõ°¡·Î ÀÎÇØ ¼ö¼ú Áß ¹× ¼ö¼ú ÈÄ ¿µ»ó Áö¿ø ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì¿Í ¼­À¯·´ÀÌ ¼Ò¾Æ ¹æ»ç¼±ÇÐ ºÐ¾ß¿¡¼­ ¿ìÀ§¸¦ Á¡Çϰí ÀÖ´Â °ÍÀº Àß È®¸³µÈ Àü¹® ±³À° ÇÁ·Î±×·¥, ÷´Ü Àåºñ¿¡ ´ëÇÑ Á¢±Ù¼º, ÀǷẸÇèÀÇ º¸±Þ¿¡ ±âÀÎÇÕ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ƯÈ÷ Àεµ, Áß±¹, ÀϺ»¿¡¼­ ±Þ¼ÓÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖÀ¸¸ç, Ãâ»êÀ² Áõ°¡¿Í 3Â÷ ¼Ò¾Æ ÀÇ·áÀÇ È®´ë°¡ ¿µ»ó ó¸® °Ç¼ö¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. Áßµ¿ ±¹°¡µéÀº ¸ðÀÚº¸°Ç ÀÎÇÁ¶ó ±¸Ãà¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, ¶óƾ¾Æ¸Þ¸®Ä«¿Í »çÇ϶ó À̳² ¾ÆÇÁ¸®Ä«´Â Á¢±Ù¼º¿¡ ¾î·Á¿òÀ» °Þ°í ÀÖÁö¸¸ °øÁߺ¸°Ç ³ë·Â°ú NGOÀÇ Áö¿øÀ» ÅëÇØ ¿ª·®À» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °áÇÙ, COVID-19, Èñ±Í À¯Àü¼º Áúȯ µî ¼¼°è Áúº´ °¨½Ã ÇÁ·Î±×·¥µµ ¼Ò¾Æ ¿µ»ó Áø´ÜÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¼Ò¾Æ ¹æ»ç¼±ÇÐ ½ÃÀåÀÇ Àå±âÀûÀÎ ¼ºÀå°ú Çõ½ÅÀÇ ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

¼Ò¾Æ ¹æ»ç¼±ÇÐ ½ÃÀåÀÇ ¼ºÀå µ¿·ÂÀº ±â¼ú Çõ½Å, ¼Ò¾Æ ƯÀ¯ÀÇ Áø´Ü ¿ä±¸¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¼Ò¾Æ °Ç°­ »óÅ °³¼±¿¡ ´ëÇÑ Àü ¼¼°èÀûÀÎ ³ë·Â¿¡ ±âÀÎÇÕ´Ï´Ù. ¼Ò¾Æ ȯÀÚ°¡ Áý´Ü °Ç°­ Àü·«ÀÇ ÃÊÁ¡ÀÌ µÇ¸é¼­ ¹æ»ç¼± ÀÇÇÐÀº ´õ ³ôÀº Á¤È®¼º, ¹Î°¨µµ, ¾ÈÀü¼ºÀ» ¹ÙÅÁÀ¸·Î ÀÌ ºÐ¾ß¿¡ ±â¿©Çϱâ À§ÇØ ÀçÁ¤Àǵǰí ÀÖ½À´Ï´Ù. ¼Ò¾Æ°ú ÀÇ»ç, ¿Ü°ú ÀÇ»ç, ½Å°æ°ú ÀÇ»ç, Á¾¾ç³»°ú ÀÇ»ç µî ´Ù¾çÇÑ ºÐ¾ß¿ÍÀÇ Çù¾÷À» ÅëÇØ Á¾ÇÕÀûÀÎ ¼Ò¾Æ ÀÇ·á¿¡¼­ ¿µ»óÀÇÇÐÀÇ ÀÓ»óÀû À¯¿ë¼ºÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù.

¿µ»ó Áø´Ü ¾÷üµéÀº Àü·«ÀûÀ¸·Î ¼Ò¾Æ Àü¿ë Á¦Ç°±º, AI Áö¿ø Áø´Ü Ç÷§Æû, ºÐ»êÇü Áø·á ¸ðµ¨À» Áö¿øÇÏ´Â ÈÞ´ë¿ë POC ¿µ»ó Áø´Ü ½Ã½ºÅÛÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. ¿ø°Ý ¿µ»ó Áø´Ü ³×Æ®¿öÅ©´Â ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ ¿ø°Ý ÆÇµ¶À» °¡´ÉÇÏ°Ô Çϰí, µðÁöÅÐ ¿µ»ó ¾ÆÄ«À̺ê(PACS)´Â ¼ºÀå°ú °ü·ÃµÈ »óÅÂÀÇ Á¾´ÜÀû ÃßÀûÀ» °£¼ÒÈ­ÇÕ´Ï´Ù. ¹æ»ç¼± À¯ÀüüÇÐ, ±â´ÉÀû ¿µ»ó Áø´Ü, ¼Ò¾ÆÀÇ Á¶¿µÁ¦ ¾ÈÀü¼º¿¡ ´ëÇÑ ¿¬±¸´Â °³ÀÎÈ­µÈ ¼Ò¾Æ Áø´ÜÀÇ »õ·Î¿î ÁöÆòÀ» ¿­°í ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ¼Ò¾Æ ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ°¡ °¡¼ÓÈ­µÇ°í ÀÖ´Â °¡¿îµ¥, ¿µ»óÀÇÇÐÀº ¾çÁúÀÇ °øÆòÇÏ°í ¹Ì·¡ÁöÇâÀûÀÎ ¼Ò¾Æ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÏ´Â µ¥ ÀÖ¾î ÇÙ½ÉÀûÀÎ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(ÃÊÀ½ÆÄ, MRI, X¼±, ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ), ¸ð´Þ¸®Æ¼(µ¶¸³Çü ±â±â ¸ð´Þ¸®Æ¼, Ź»ó ±â±â ¸ð´Þ¸®Æ¼, ÈÞ´ë ±â±â ¸ð´Þ¸®Æ¼), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ÃÖÁ¾»ç¿ëÀÚ, ¼Ò¾Æ°ú Ŭ¸®´Ð ÃÖÁ¾»ç¿ëÀÚ, Áø´Ü ¼¾ÅÍ ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 36°³»ç)

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ÀÎÀ§ÀûÀÎ ¸ÅÃâ¿ø°¡ Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Global Industry Analysts´Â ¼¼°è ÁÖ¿ä ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®(1,4,949¸í), ½ÌÅ©ÅÊÅ©(62°³ ±â°ü), ¹«¿ª ¹× »ê¾÷ ´Üü(171°³ ±â°ü)ÀÇ Àü¹®°¡µéÀÇ ÀǰßÀ» ¸é¹ÐÈ÷ °ËÅäÇÏ¿© »ýŰ迡 ¹ÌÄ¡´Â ¿µÇâÀ» Æò°¡ÇÏ°í »õ·Î¿î ½ÃÀå Çö½Ç¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¸ðµç ÁÖ¿ä ±¹°¡ÀÇ Àü¹®°¡¿Í °æÁ¦ÇÐÀÚµéÀÌ °ü¼¼¿Í ±×°ÍÀÌ ÀÚ±¹¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀǰßÀ» ÃßÀû Á¶»çÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀÌ·¯ÇÑ È¥¶õÀÌ ÇâÈÄ 2-3°³¿ù ³»¿¡ ¸¶¹«¸®µÇ°í »õ·Î¿î ¼¼°è Áú¼­°¡ º¸´Ù ¸íÈ®ÇÏ°Ô È®¸³µÉ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖÀ¸¸ç, Global Industry Analysts´Â ÀÌ·¯ÇÑ »óȲÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇϰí ÀÖ½À´Ï´Ù.

2025³â 4¿ù : Çù»ó ´Ü°è

À̹ø 4¿ù º¸°í¼­¿¡¼­´Â °ü¼¼°¡ ¼¼°è ½ÃÀå Àüü¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú Áö¿ªº° ½ÃÀå Á¶Á¤¿¡ ´ëÇØ ¼Ò°³ÇÕ´Ï´Ù. ´ç»çÀÇ ¿¹ÃøÀº °ú°Å µ¥ÀÌÅÍ¿Í ÁøÈ­ÇÏ´Â ½ÃÀå ¿µÇâ¿äÀÎÀ» ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù.

2025³â 7¿ù : ÃÖÁ¾ °ü¼¼ Àç¼³Á¤

°í°´´Ôµé²²´Â °¢ ±¹°¡º° ÃÖÁ¾ ¸®¼ÂÀÌ ¹ßÇ¥µÈ ÈÄ 7¿ù¿¡ ¹«·á ¾÷µ¥ÀÌÆ® ¹öÀüÀ» Á¦°øÇØ µå¸³´Ï´Ù. ÃÖÁ¾ ¾÷µ¥ÀÌÆ® ¹öÀü¿¡´Â ¸íÈ®ÇÏ°Ô Á¤ÀÇµÈ °ü¼¼ ¿µÇ⠺м®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

»óÈ£ ¹× ¾çÀÚ °£ ¹«¿ª°ú °ü¼¼ÀÇ ¿µÇ⠺м®:

¹Ì±¹ <> Áß±¹ <> ¸ß½ÃÄÚ <> ij³ª´Ù <> EU <> ÀϺ» <> Àεµ <> ±âŸ 176°³±¹

¾÷°è ÃÖ°íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ® : Global Industry AnalystsÀÇ Áö½Ä ±â¹ÝÀº ±¹°¡, ½ÌÅ©ÅÊÅ©, ¹«¿ª ¹× »ê¾÷ ´Üü, ´ë±â¾÷, ±×¸®°í ¼¼°è °è·® °æÁ¦ »óȲÀÇ Àü·Ê ¾ø´Â ÆÐ·¯´ÙÀÓ ÀüȯÀÇ ¿µÇâÀ» °øÀ¯ÇÏ´Â ºÐ¾ßº° Àü¹®°¡ µî °¡Àå ¿µÇâ·Â ÀÖ´Â ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ Æ÷ÇÔÇÑ 14,949¸íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ ÃßÀûÇϰí ÀÖ½À´Ï´Ù. 16,491°³ ÀÌ»óÀÇ º¸°í¼­ ´ëºÎºÐ¿¡ ¸¶ÀϽºÅæ¿¡ ±â¹ÝÇÑ 2´Ü°è Ãâ½Ã ÀÏÁ¤ÀÌ Àû¿ëµÇ¾î ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Pediatric Radiology Market to Reach US$7.8 Billion by 2030

The global market for Pediatric Radiology estimated at US$6.5 Billion in the year 2024, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Ultrasound, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the MRI segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 5.7% CAGR

The Pediatric Radiology market in the U.S. is estimated at US$1.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Pediatric Radiology Market - Key Trends & Drivers Summarized

Why Is Pediatric Radiology Becoming a Distinct and Rapidly Evolving Subspecialty in Medical Imaging?

Pediatric radiology is emerging as a critical and specialized field within diagnostic imaging, tailored to the unique anatomical, physiological, and developmental characteristics of infants, children, and adolescents. Unlike adult radiology, pediatric imaging demands customized equipment settings, radiation dose adjustments, sedation protocols, and specialized interpretation skills to account for dynamic growth patterns and disease presentations that vary significantly with age. This subspecialty plays a crucial role in early diagnosis, treatment planning, and disease monitoring across a spectrum of pediatric conditions including congenital anomalies, infections, trauma, and oncology.

The increasing prevalence of chronic pediatric conditions such as congenital heart defects, cystic fibrosis, epilepsy, and pediatric cancers is expanding the clinical need for advanced imaging modalities. Additionally, neonatal intensive care units (NICUs), pediatric emergency departments, and specialized children’s hospitals are investing in dedicated radiology units to reduce diagnostic delays and improve outcomes. As health systems around the world adopt a more child-centric approach, pediatric radiology is becoming a fundamental pillar in ensuring accurate, safe, and timely diagnostic support for the youngest patients.

How Are Imaging Modalities and Safety Standards Evolving to Meet Pediatric Radiology Demands?

The field is witnessing rapid advancements in imaging technology tailored for pediatric use. Low-dose computed tomography (CT) scanners with iterative reconstruction, high-resolution ultrasonography, and pediatric-specific magnetic resonance imaging (MRI) protocols are minimizing exposure while maintaining diagnostic accuracy. Pediatric fluoroscopy suites, contrast-enhanced ultrasound (CEUS), and 3D imaging are also gaining traction for evaluating gastrointestinal, urinary, and vascular systems without resorting to invasive procedures.

Radiation safety remains a central concern, leading to widespread adoption of the “As Low As Reasonably Achievable” (ALARA) principle in pediatric radiology protocols. Shielding methods, adaptive dose modulation, and automated exposure control systems are being embedded into imaging platforms. Furthermore, software tools for image post-processing, noise reduction, and AI-assisted diagnosis are reducing the need for repeat scans. Pediatric-friendly environments with child-life specialists, audiovisual distractions, and non-pharmacological calming methods are enhancing cooperation and scan quality, making pediatric imaging safer and more effective across settings.

Which Institutions, Disease Profiles, and Geographic Regions Are Driving Demand for Pediatric Radiology Services?

Tertiary care children’s hospitals, academic medical centers, and specialized pediatric clinics are leading users of pediatric radiology services. High imaging demand is concentrated in neonatal care, pediatric orthopedics, cardiology, oncology, and emergency medicine. Common indications include neurodevelopmental assessments, skeletal dysplasia evaluations, trauma imaging, and cancer staging. The rise in pediatric surgical interventions, including congenital anomaly repairs and organ transplants, further fuels demand for intraoperative and postoperative imaging support.

North America and Western Europe dominate the pediatric radiology landscape due to well-established subspecialty training programs, access to advanced equipment, and widespread health insurance coverage. Asia-Pacific is seeing rapid growth, particularly in India, China, and Japan, where rising birth rates and expanding tertiary pediatric care are boosting imaging volumes. Middle Eastern nations are investing in maternal and child health infrastructure, while Latin America and Sub-Saharan Africa face challenges in access but are improving capacity through public health initiatives and NGO support. Global disease surveillance programs are also driving pediatric imaging in the context of tuberculosis, COVID-19, and rare genetic disorders.

What Is Driving Long-Term Growth and Innovation in the Pediatric Radiology Market?

The growth in the pediatric radiology market is driven by technological innovation, growing recognition of pediatric-specific diagnostic needs, and the global commitment to improving child health outcomes. As pediatric patients become a focal point in population health strategies, radiology is being redefined to serve this segment with greater precision, sensitivity, and safety. Cross-disciplinary collaboration with pediatricians, surgeons, neurologists, and oncologists is strengthening the clinical utility of radiology in comprehensive pediatric care.

Strategically, imaging vendors are developing pediatric-dedicated product lines, AI-assisted diagnostic platforms, and portable point-of-care imaging systems to support decentralized care models. Tele-radiology networks are enabling remote interpretation in underserved regions, while digital imaging archives (PACS) are streamlining longitudinal tracking of growth-related conditions. Research into radiogenomics, functional imaging, and contrast safety in children is opening new frontiers for personalized pediatric diagnostics. As investment in pediatric healthcare infrastructure accelerates globally, radiology will remain central to delivering high-quality, equitable, and future-ready child health services.

SCOPE OF STUDY:

The report analyzes the Pediatric Radiology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Ultrasound, MRI, X-ray, Computed Tomography); Modality (Standalone Devices Modality, Table-top Devices Modality, Portable Devices Modality); End-Use (Hospitals End-Use, Pediatric Clinics End-Use, Diagnostic Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â